- Home
- NNAVW vs OSRHW Comparison
NNAVW vs OSRHW Comparison
Compare NNAVW & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNAVW
- OSRHW
- Stock Information
- Founded
- NNAVW 2007
- OSRHW N/A
- Country
- NNAVW United States
- OSRHW United States
- Employees
- NNAVW 96
- OSRHW 21
- Industry
- NNAVW Industrial Machinery/Components
- OSRHW
- Sector
- NNAVW Industrials
- OSRHW
- Exchange
- NNAVW Nasdaq
- OSRHW Nasdaq
- Market Cap
- NNAVW N/A
- OSRHW N/A
- IPO Year
- NNAVW N/A
- OSRHW 2023
- Fundamental
- Price
- NNAVW $7.07
- OSRHW $0.05
- Analyst Decision
- NNAVW
- OSRHW
- Analyst Count
- NNAVW 0
- OSRHW 0
- Target Price
- NNAVW N/A
- OSRHW N/A
- AVG Volume (30 Days)
- NNAVW 53.1K
- OSRHW N/A
- Earning Date
- NNAVW 03-12-2025
- OSRHW N/A
- Dividend Yield
- NNAVW N/A
- OSRHW N/A
- EPS Growth
- NNAVW N/A
- OSRHW N/A
- EPS
- NNAVW N/A
- OSRHW N/A
- Revenue
- NNAVW $4,963,000.00
- OSRHW N/A
- Revenue This Year
- NNAVW N/A
- OSRHW N/A
- Revenue Next Year
- NNAVW N/A
- OSRHW N/A
- P/E Ratio
- NNAVW N/A
- OSRHW N/A
- Revenue Growth
- NNAVW 43.44
- OSRHW N/A
- 52 Week Low
- NNAVW $4.47
- OSRHW N/A
- 52 Week High
- NNAVW $4.70
- OSRHW N/A
- Technical
- Relative Strength Index (RSI)
- NNAVW N/A
- OSRHW N/A
- Support Level
- NNAVW N/A
- OSRHW N/A
- Resistance Level
- NNAVW N/A
- OSRHW N/A
- Average True Range (ATR)
- NNAVW 0.00
- OSRHW 0.00
- MACD
- NNAVW 0.00
- OSRHW 0.00
- Stochastic Oscillator
- NNAVW 0.00
- OSRHW 0.00
About NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.